Roundup of Coverage on $456 Million Government Vaccine Contract with J&J
Johnson & Johnson Says Its Coronavirus Vaccine Could Be Ready Early Next Year
March 30, 2020 -- This article discusses the recent efforts by J&J to develop a coronavirus after being contracted by the US government to develop vaccines.
Johnson & Johnson coronavirus vaccine could scale up to a billion doses by end of 2021: CEO
March 31, 2019 -- This article discusses how J&J is working with Beth Israel Deaconess Medical Center to start picking people to test a new coronavirus vaccine on.
"This would ordinarily take about five years, but as we all know these are very different times," Gorsky said. "We've got a team of scientists literally working around the clock since January."
Johnson & Johnson CEO on the race to make a coronavirus vaccine
March 31, 2020 -- This article includes comments from Alex Gorsky about what J&J is doing to develop a coronavirus vaccine.
Johnson & Johnson CEO on how close company is to coronavirus vaccine
March 30, 2020 -- This video shows Alex Gorsky discussing J&J vaccine development efforts on Squawk Box.
March 22, 2020 -- This is an article about Alex Gorsky and his impressions on coronavirus and the ability to create a vaccine. This interview with Gorsky discusses the science behind finding a vaccine, company efforts and J&J supply chains.
“Right now, we are making very significant investment, somewhat at risk, knowing that we need to have adequate supply in parallel with knowing that the vaccine actually works,” he said.
When Bartiromo asked Gorsky if he was willing to take his supply chain entirely back to America instead of relying on China for active ingredients in prescription drugs, he responded, “I think the facts are that most of the large companies now have large global integrative supply chains.”
Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
March 18, 2020 -- This article discusses how J&J doesn’t have a valid vaccine candidate for coronavirus and appears to be falling behind other companies in the race to find a vaccine.
“Big old Johnson & Johnson (NYSE:JNJ) The healthcare conglomerate doesn't even have a candidate yet.”
“The company started working on a vaccine in January but only expects to have a candidate picked out by the end of this month, according to an interview with Johnson & Johnson's chief scientific officer, Paul Stoffels, on CNBC.”
Beth Israel is working with Johnson & Johnson on a coronavirus vaccine
March 12, 2020 -- This article discusses a partnership between J&J and Beth Israel Medical Center in the search for a coronavirus vaccine.
“Beth Israel and Janssen have collaborated for more than a decade on vaccine programs for other illnesses, including Zika virus disease and HIV. They signed an agreement to work together on coronavirus on Jan. 31, Barouch said, just three weeks after Chinese scientists sequenced the genome of the virus and posted it online. Financial terms haven’t been disclosed.”
